AVAIS MASUD
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NEPTUNE, NJ NPI 1114983541
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NJ Acerta Pharma LLC All categories
General Payments — all program years on this page
$7,130.66
- Category: General Payments
- Program years: PY2018–2024
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,200.98 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,950.00 | 1 |
| Honoraria | $900.00 | 1 |
| Food and Beverage | $307.98 | 4 |
| Education | $43.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $3,087.86 | 3 |
| Daxor Corporation | $900.00 | 1 |
| Mallinckrodt Hospital Products Inc. | $150.00 | 1 |
| Aurinia Pharma U.S., Inc. | $43.00 | 1 |
| OPKO Pharmaceuticals, LLC | $20.12 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104200959 | AstraZeneca Pharmaceuticals LP | $2,950.00 | 03/15/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Undisputed | 01/23/2026 | View at CMS |
| 1105272501 | AstraZeneca Pharmaceuticals LP | $12.95 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105460042 | AstraZeneca Pharmaceuticals LP | $124.91 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1112847056 | OPKO Pharmaceuticals, LLC | $20.12 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136815837 | Daxor Corporation | $900.00 | 04/22/2024 | Honoraria | Undisputed | 01/23/2026 | View at CMS |
| 1145104783 | Mallinckrodt Hospital Products Inc. | $150.00 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150687083 | Aurinia Pharma U.S., Inc. | $43.00 | 01/24/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.